Landscapes / Companies
Daré Bioscience, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 6 in all
Trials
2 active
8 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
DARE-HPVnot checked |
— |
Phase 2 | Oct 2027Phase 2 trial completes | ||
| Next date | Oct 2027 · Phase 2 trial completes | ||||
| Also tested for | Human Papilloma Virus (HPV), High-risk Human Papillomavirus Infection | ||||
| Open drug page | |||||
DARE-PTB1not checked |
— |
Phase 1 | Nov 2027Phase 1 trial completes | ||
| Next date | Nov 2027 · Phase 1 trial completes | ||||
| Also tested for | Pre Term Birth | ||||
| Open drug page | |||||
About
- No active trial
- DARE-BV1, DARE-BV1clindamycin phosphate vaginal gel, Diclofenac 1%, Diclofenac 3%
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021